# Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

> Federal funding opportunity · **POSTED** · National Institutes of Health · close: **11/10/2026**

## Key facts

- **Opportunity ID:** 360400
- **Opportunity number:** RFA-NS-26-001
- **Agency:** National Institutes of Health
- **Status:** posted
- **Document type:** synopsis
- **Open date:** 05/04/2026
- **Close date:** 11/10/2026
- **CFDA codes:** 93.853

## Primary source

Grants.gov opportunity detail: https://www.grants.gov/search-results-detail/360400

## Citation

> US Grants.gov, funding opportunity 360400 (RFA-NS-26-001). Retrieved via AI Analytics 2026-05-16 from https://api.ai-analytics.org/opportunity/360400. Licensed CC0.

---

*[Grants.gov dataset](/datasets/grants-gov) · CC0 1.0*